General
Preferred name
FARGLITAZAR
Synonyms
G1-262570 ()
GI-262570X ()
Gi262570 ()
GI262570X ()
GI-262570 ()
P&D ID
PD046820
CAS
196808-45-4
Tags
drug candidate
natural product
available
Drug indication
Type-1 diabetes
Drug Status
investigational
Max Phase
Phase 2
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
ChEMBL Drugs
DrugMAP
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
21
Properties
(calculated by RDKit )
Molecular Weight
546.22
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
12
Ring Count
5
Aromatic Ring Count
5
cLogP
6.61
TPSA
101.66
Fraction CSP3
0.15
Chiral centers
1.0
Largest ring
6.0
QED
0.17
Structural alerts
1
anthranil_one_A(38)
c:1:c:c:c:c(:c:1-[#7&!H0;!H1,!$([#7]-[#6]=[#8])])-[#6](-[#6]:[#6])=[#8]
PAINS Family B
Related compounds
Custom attributes
(extracted from source data)
Source data
